Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

'Copenhagen accord has inbuilt hazards'
The Copenhagen accord on climate change was a partial success for India but it has certain “inbuilt hazards” of which the developing countries have to be wary, Environment Minister Jairam Ramesh has said.

Bharat Biotech secures patent for Lysostaphin
Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech International said on Wednesday that its anti-staphylococcal molecule Lysostaphin had secured patent rights in US, Europe, China, Australia and other nations.

News of the day

Maharatna status for top PSUs likely in a month
The government is considering a proposal to elevate some Navratna PSUs to Maharatna companies to allow them more freedom regarding investment, Bhaskar Chatterjee, secretary of the Union government"s department of public enterprises, today said.
Business Opportunities

Wockhardt ends weak despite US FDA nod for generic drug

Wockhardt closed at Rs 175, lower by Rs 5 or 2%, on the BSE. - Wockhardt, Sun get US okay for generic drug - Wockhardt gets FDA nod for Nicardipine injections - Not the right medicine - Wockhardt bleeds due to Rs 284-crore hit - Indiabulls Power ends at 13% discount - Bhupesh Bhandari: The new pharmaceutical order">Bhupesh Bhandari: The new pharmaceutical order The stock opened at Rs 184 and touched a high of Rs 185 and a low of 174 during the day. A total of 84,975 shares were traded during the day as against the two-week average of 94,037 shares. _________________________________________________________________________ (Updated at 1052 am) Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug. Following which, share price of Wockhardt jumped to a high of Rs 185, and is now up 1.5% at Rs 183. The counter has seen trades of around 36,600 shares so far on the BSE. Meanwhile, Sun Pharma is trading flat at Rs 1,440. Around 5,880 shares have changed hands at the counter on the BSE. Click here to read: Wockhardt, Sun get US okay for generic drug


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009